NYSE:EW - Edwards Lifesciences Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $87.72
  • Forecasted Upside: 2.89 %
  • Number of Analysts: 20
  • Breakdown:
  • 2 Sell Ratings
  • 5 Hold Ratings
  • 13 Buy Ratings
  • 0 Strong Buy Ratings
$85.26
▲ +1.05 (1.25%)
1 month | 3 months | 12 months
Get New Edwards Lifesciences Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EW and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EW

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$87.72
▲ +2.89% Upside Potential
This price target is based on 20 analysts offering 12 month price targets for Edwards Lifesciences in the last 3 months. The average price target is $87.72, with a high forecast of $105.00 and a low forecast of $51.67. The average price target represents a 2.89% upside from the last price of $85.26.
Buy
The current consensus among 20 polled investment analysts is to buy stock in Edwards Lifesciences. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 12 buy ratings
  • 8 hold ratings
  • 1 sell ratings
6/6/2019
  • 0 strong buy ratings
  • 12 buy ratings
  • 7 hold ratings
  • 1 sell ratings
9/4/2019
  • 0 strong buy ratings
  • 12 buy ratings
  • 5 hold ratings
  • 1 sell ratings
12/3/2019
  • 0 strong buy ratings
  • 15 buy ratings
  • 6 hold ratings
  • 1 sell ratings
3/2/2020
  • 0 strong buy ratings
  • 16 buy ratings
  • 6 hold ratings
  • 1 sell ratings
5/31/2020
  • 0 strong buy ratings
  • 14 buy ratings
  • 5 hold ratings
  • 1 sell ratings
8/29/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 5 hold ratings
  • 2 sell ratings
10/28/2020
  • 0 strong buy ratings
  • 13 buy ratings
  • 5 hold ratings
  • 2 sell ratings
11/27/2020

Latest Recommendations

  • 0 strong buy ratings
  • 13 buy ratings
  • 5 hold ratings
  • 2 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/18/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$84.00 ➝ $87.00Low
i
10/27/2020Jefferies Financial GroupBoost Price TargetBuy$95.00 ➝ $105.00Medium
i
10/22/2020Credit Suisse GroupBoost Price TargetOutperform$92.00 ➝ $97.00High
i
Rating by Matt Miksic at Credit Suisse Group AG
10/22/2020Raymond JamesBoost Price TargetOutperform$88.00 ➝ $90.00High
i
10/19/2020CowenBoost Price TargetOutperform$85.00 ➝ $100.00Medium
i
10/14/2020Piper SandlerBoost Price TargetOverweight$91.00 ➝ $93.00Low
i
10/12/2020SVB LeerinkBoost Price TargetOutperform$95.00 ➝ $100.00Low
i
Rating by D. Antalffy at SVB Leerink LLC
9/11/2020Wolfe ResearchInitiated CoverageUnderperformLow
i
7/24/2020Stifel NicolausBoost Price TargetBuy$85.00 ➝ $90.00Low
i
7/24/2020Canaccord GenuityBoost Price TargetBuy$86.00 ➝ $89.00Medium
i
7/24/2020Jefferies Financial GroupBoost Price TargetBuy$87.00 ➝ $95.00Low
i
7/24/2020Credit Suisse GroupBoost Price TargetOutperform$88.00 ➝ $92.00High
i
Rating by Matt Miksic at Credit Suisse Group AG
7/24/2020Morgan StanleyBoost Price TargetOverweight$83.00 ➝ $88.00High
i
7/24/2020SVB LeerinkBoost Price TargetOutperform$90.00 ➝ $95.00High
i
Rating by D. Antalffy at SVB Leerink LLC
7/24/2020Raymond JamesBoost Price TargetOutperform$83.00 ➝ $88.00High
i
7/24/2020Piper SandlerBoost Price TargetPositive ➝ Overweight$88.00 ➝ $91.00High
i
7/13/2020OppenheimerInitiated CoverageBuy$93.00High
i
Rating by Suraj Kalia at Oppenheimer Holdings Inc.
6/29/2020Morgan StanleyLower Price TargetOverweight$83.33 ➝ $83.00Low
i
6/2/2020Credit Suisse GroupLower Price TargetOutperform$88.00High
i
Rating by Matt Miksic at Credit Suisse Group AG
6/1/2020Morgan StanleyLower Price TargetOverweight$83.33 ➝ $83.00N/A
i
4/28/2020Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$83.33 ➝ $76.67High
i
4/27/2020BarclaysReiterated RatingUnderweight$55.00 ➝ $51.67High
i
4/24/2020CfraBoost Price TargetBuy$67.00 ➝ $77.00Low
i
4/24/2020Raymond JamesBoost Price TargetOutperform$76.67 ➝ $83.33Low
i
4/24/2020Stifel NicolausBoost Price TargetBuy$76.67 ➝ $85.00Low
i
4/24/2020Piper SandlerLower Price TargetOverweight$90.00 ➝ $88.33Low
i
4/24/2020Morgan StanleyBoost Price TargetOverweight$80.33 ➝ $83.33High
i
4/24/2020Credit Suisse GroupBoost Price TargetOutperform$86.67 ➝ $87.33High
i
4/24/2020Wells Fargo & CompanyBoost Price TargetOverweight$71.67 ➝ $83.33High
i
4/24/2020Canaccord GenuityReiterated RatingBuyHigh
i
Rating by Jason Mills at Canaccord Genuity
4/24/2020CitigroupBoost Price TargetBuy$80.00 ➝ $85.00High
i
4/23/2020BTIG ResearchReiterated RatingHoldHigh
i
Rating by Marie Thibault at BTIG Research
4/22/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$81.67 ➝ $75.00Low
i
4/20/2020CowenLower Price TargetTop Pick ➝ Outperform$91.67 ➝ $83.33Medium
i
Rating by Josh Jennings at Cowen Inc
4/19/2020SVB LeerinkDowngradeOutperform ➝ Market PerformMedium
i
Rating by D. Antalffy at SVB Leerink LLC
4/17/2020SVB LeerinkUpgradeMarket Perform ➝ Outperform$90.00High
i
Rating by D. Antalffy at SVB Leerink LLC
4/9/2020Raymond JamesLower Price TargetOutperform$87.67 ➝ $76.67High
i
4/6/2020Wells Fargo & CompanyLower Price TargetOverweight$90.67 ➝ $71.67Low
i
3/27/2020Morgan StanleyLower Price TargetOverweight$90.00 ➝ $80.33Low
i
3/27/2020CitigroupLower Price TargetBuy$84.00 ➝ $80.00Low
i
3/13/2020CfraUpgradeSell ➝ Hold$69.00 ➝ $67.00High
i
3/6/2020Credit Suisse GroupLower Price TargetOutperform$92.67 ➝ $89.00Low
i
3/4/2020CitigroupInitiated CoverageBuy$84.00Low
i
2/25/2020Canaccord GenuityReiterated RatingBuyLow
i
Rating by Jason Mills at Canaccord Genuity
2/12/2020The Goldman Sachs GroupInitiated CoverageNeutral$84.33Low
i
2/6/2020BTIG ResearchInitiated CoverageHoldMedium
i
1/31/2020CfraBoost Price TargetSell$68.33 ➝ $69.00High
i
1/31/2020Stifel NicolausBoost Price TargetBuy$91.67 ➝ $93.33High
i
1/31/2020Wells Fargo & CompanyBoost Price TargetOverweight$90.00 ➝ $90.67High
i
1/31/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$78.67 ➝ $81.67High
i
1/31/2020Credit Suisse GroupBoost Price TargetOutperform$91.67 ➝ $92.67High
i
1/31/2020Piper SandlerBoost Price TargetOverweight$87.33 ➝ $90.00High
i
1/31/2020UBS GroupBoost Price TargetNeutral$85.00 ➝ $86.67High
i
1/31/2020Canaccord GenuityReiterated RatingBuy$100.00High
i
Rating by Jason Mills at Canaccord Genuity
1/9/2020OppenheimerUpgradeMarket Perform ➝ Buy$93.33Medium
i
Rating by Suraj Kalia at Oppenheimer Holdings Inc.
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageHold$54.67Low
i
12/17/2019CowenReiterated RatingBuy$91.67Medium
i
Rating by Josh Jennings at Cowen Inc
12/9/2019Piper Jaffray CompaniesBoost Price TargetOverweight$85.00 ➝ $87.33High
i
Rating by William Quirk at Piper Jaffray Companies
12/6/2019Canaccord GenuityReiterated RatingBuy$86.67Low
i
Rating by Jason Mills at Canaccord Genuity
12/6/2019UBS GroupBoost Price TargetNeutral$83.33 ➝ $85.00High
i
12/6/2019Wells Fargo & CompanyBoost Price TargetOutperform$87.33 ➝ $90.00High
i
12/6/2019Credit Suisse GroupBoost Price TargetOutperform$89.67 ➝ $91.67High
i
12/6/2019Morgan StanleyBoost Price TargetOverweight$82.67 ➝ $90.00High
i
12/6/2019Raymond JamesBoost Price TargetOutperform$85.00 ➝ $87.67High
i
12/3/2019Jefferies Financial GroupBoost Price TargetBuy$85.00 ➝ $95.00Low
i
10/24/2019Canaccord GenuityBoost Price TargetBuy$83.33 ➝ $86.67High
i
10/24/2019Raymond JamesBoost Price TargetOutperform$83.33 ➝ $85.00High
i
10/24/2019CowenBoost Price TargetOutperform ➝ Positive$83.33 ➝ $88.33High
i
10/24/2019Wells Fargo & CompanyBoost Price TargetOutperform$83.33 ➝ $87.33High
i
10/24/2019Piper Jaffray CompaniesBoost Price TargetOverweight$80.00 ➝ $85.00High
i
Rating by William Quirk at Piper Jaffray Companies
10/22/2019Royal Bank of CanadaBoost Price TargetBuy ➝ Outperform$72.33 ➝ $83.33Medium
i
10/16/2019UBS GroupBoost Price TargetNeutral$68.33 ➝ $76.67Low
i
10/14/2019Raymond JamesBoost Price TargetOutperform$77.33 ➝ $83.33Low
i
10/14/2019Credit Suisse GroupBoost Price TargetPositive ➝ Outperform$75.33 ➝ $87.00Low
i
9/23/2019Piper Jaffray CompaniesInitiated CoverageOverweight$80.00 ➝ $80.00Low
i
9/6/2019Wells Fargo & CompanyBoost Price TargetOutperform$73.33 ➝ $83.33Low
i
7/26/2019CitigroupSet Price TargetSell$53.00Low
i
Rating by Amit Hazan at Citigroup Inc.
7/25/2019BTIG ResearchReiterated RatingHoldLow
i
7/24/2019BMO Capital MarketsBoost Price TargetOutperform$68.00 ➝ $74.67Low
i
7/24/2019JPMorgan Chase & Co.Boost Price TargetNeutral$63.33 ➝ $75.00Low
i
7/24/2019Bank of AmericaReiterated RatingBuy ➝ Buy$71.67 ➝ $75.00Low
i
7/24/2019Wells Fargo & CompanyBoost Price TargetOutperform$69.00 ➝ $73.33High
i
7/24/2019Morgan StanleyBoost Price TargetOverweight$70.00 ➝ $76.00High
i
7/24/2019Raymond JamesBoost Price TargetOutperform$66.67 ➝ $77.33High
i
7/24/2019BarclaysBoost Price TargetUnderweight$53.33 ➝ $58.33High
i
7/24/2019Credit Suisse GroupBoost Price TargetOutperform$73.67 ➝ $75.33High
i
7/24/2019Jefferies Financial GroupBoost Price TargetBuy$70.00 ➝ $81.67High
i
7/24/2019Canaccord GenuityBoost Price TargetBuy$71.67 ➝ $83.33High
i
7/16/2019Morgan StanleyBoost Price TargetOverweight$65.67 ➝ $70.00Medium
i
4/24/2019Stifel NicolausBoost Price TargetBuy ➝ Buy$63.33 ➝ $66.67Low
i
4/24/2019Deutsche Bank AktiengesellschaftBoost Price TargetHold ➝ Hold$54.67 ➝ $61.33Low
i
4/24/2019Jefferies Financial GroupBoost Price TargetBuy$65.00 ➝ $70.00Low
i
4/24/2019Raymond JamesLower Price TargetOutperform ➝ Outperform$70.00 ➝ $66.67Low
i
4/24/2019BTIG ResearchReiterated RatingHoldLow
i
4/15/2019Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$63.00 ➝ $73.67Low
i
3/27/2019JPMorgan Chase & Co.Boost Price TargetNeutral$58.33 ➝ $63.33Low
i
3/25/2019BarclaysBoost Price TargetUnderweight$50.00 ➝ $53.33Low
i
Rating by Kristen Stewart at Barclays PLC
3/22/2019BMO Capital MarketsBoost Price TargetOutperform$68.00Low
i
3/18/2019Morgan StanleyBoost Price TargetOverweight ➝ Overweight$60.00 ➝ $65.67High
i
3/18/2019Wells Fargo & CompanyBoost Price TargetOutperform$62.67 ➝ $67.33High
i
3/18/2019Bank of AmericaBoost Price TargetBuy ➝ Buy$63.33 ➝ $71.67Medium
i
3/18/2019Canaccord GenuityReiterated RatingBuy ➝ Buy$63.33 ➝ $71.67High
i
3/12/2019UBS GroupBoost Price TargetNeutral ➝ Neutral$58.33 ➝ $60.00Medium
i
2/25/2019CitigroupBoost Price TargetSell ➝ Sell$39.67 ➝ $43.33Medium
i
2/4/2019CowenReiterated RatingBuyMedium
i
Rating by Josh Jennings at Cowen Inc
2/3/2019Stifel NicolausReiterated RatingBuy$63.33Medium
i
1/18/2019Bank of AmericaUpgradeNeutral ➝ Buy$60.00 ➝ $63.33High
i
1/16/2019Canaccord GenuityBoost Price TargetBuy ➝ Positive$59.00 ➝ $62.00High
i
1/2/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold ➝ Hold$54.67High
i
1/2/2019CitigroupBoost Price TargetSell ➝ Sell$39.33 ➝ $39.67Low
i
12/17/2018Credit Suisse GroupInitiated CoverageOutperform$62.67Low
i
12/10/2018CowenSet Price TargetBuy$63.33Low
i
Rating by Josh Jennings at Cowen Inc
12/7/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$52.33 ➝ $60.00Medium
i
12/6/2018Stifel NicolausReiterated RatingPositiveHigh
i
12/6/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$53.33 ➝ $58.33High
i
12/6/2018Royal Bank of CanadaBoost Price TargetOutperform$58.33High
i
12/6/2018Jefferies Financial GroupBoost Price TargetPositive ➝ Buy$56.00 ➝ $60.00High
i
11/30/2018CowenSet Price TargetBuy$63.33Low
i
Rating by Josh Jennings at Cowen Inc
11/27/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$55.00 ➝ $55.00High
i
10/29/2018CitigroupLower Price TargetSell ➝ Sell$40.33 ➝ $39.33High
i
10/24/2018BarclaysSet Price TargetSell$47.67High
i
Rating by Kristen Stewart at Barclays PLC
10/15/2018BarclaysInitiated CoverageUnderweight ➝ Underweight$47.67High
i
10/11/2018Morgan StanleyBoost Price TargetOverweight$50.00 ➝ $52.33Medium
i
10/11/2018Northland SecuritiesReiterated RatingHold$40.00Medium
i
10/2/2018Bank of AmericaDowngradeBuy ➝ NeutralMedium
i
10/2/2018GuggenheimDowngradeBuy ➝ NeutralHigh
i
9/28/2018SunTrust BanksBoost Price TargetBuy$66.67Medium
i
8/10/2018SunTrust BanksLower Price TargetBuy$56.67Low
i
7/31/2018CitigroupBoost Price TargetSell ➝ Sell$38.33 ➝ $39.33Low
i
7/27/2018GuggenheimReiterated RatingBuy$56.67Low
i
7/27/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$46.00 ➝ $50.00Medium
i
7/27/2018Wells Fargo & CompanyBoost Price TargetOutperform ➝ Outperform$50.67 ➝ $56.67Medium
i
7/27/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$44.33 ➝ $50.00High
i
7/27/2018Jefferies Financial GroupReiterated RatingBuy$56.00High
i
7/27/2018Northland SecuritiesReiterated RatingHold$40.00High
i
7/10/2018BMO Capital MarketsBoost Price TargetOutperform$54.00Low
i
6/27/2018Sanford C. BernsteinInitiated CoverageMarket Perform$55.00High
i
5/31/2018Raymond JamesInitiated CoverageOutperform$50.67Low
i
5/23/2018Royal Bank of CanadaBoost Price TargetOutperform$48.33High
i
4/25/2018Royal Bank of CanadaReiterated RatingOutperform$46.67Low
i
4/25/2018Northland SecuritiesDowngradeOutperform ➝ Market PerformHigh
i
4/10/2018SunTrust BanksReiterated RatingBuy$60.00Medium
i
Rating by Bruce Nudell at SunTrust Banks, Inc.
3/20/2018CowenReiterated RatingBuy$55.00Low
i
Rating by Josh Jennings at Cowen Inc
2/2/2018GuggenheimReiterated RatingBuy$54.00Low
i
2/2/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$45.00 ➝ $46.67High
i
2/2/2018Stifel NicolausReiterated RatingBuy$51.67High
i
2/2/2018BarclaysBoost Price TargetOverweight ➝ Overweight$45.00 ➝ $51.67High
i
2/2/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$43.33 ➝ $46.00High
i
2/2/2018Canaccord GenuityReiterated RatingBuy ➝ Buy$46.67 ➝ $58.00High
i
2/1/2018CowenReiterated RatingBuy$50.00High
i
Rating by Josh Jennings at Cowen Inc
1/31/2018SunTrust BanksReiterated RatingBuy$50.00Low
i
Rating by Bruce Nudell at SunTrust Banks, Inc.
1/4/2018BarclaysUpgradeEqual Weight ➝ Overweight$41.67 ➝ $45.00Low
i
1/3/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$46.67High
i
1/2/2018JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralMedium
i
12/10/2017CowenSet Price TargetBuy$45.00Low
i
Rating by Josh Jennings at Cowen Inc
12/8/2017BMO Capital MarketsReiterated RatingBuy$45.67Low
i
11/29/2017Canaccord GenuityReiterated RatingBuy$45.67Low
i
10/26/2017Deutsche Bank AktiengesellschaftLower Price TargetHold$40.67 ➝ $38.33N/A
i
10/26/2017Morgan StanleyLower Price TargetOverweight$44.33 ➝ $40.00N/A
i
10/25/2017BarclaysLower Price TargetEqual Weight$40.00 ➝ $39.33N/A
i
10/25/2017SunTrust BanksSet Price TargetBuy$41.33N/A
i
10/25/2017Canaccord GenuityReiterated RatingBuy$51.67 ➝ $45.00N/A
i
10/12/2017CowenReiterated RatingBuy$45.00N/A
i
10/8/2017Canaccord GenuityReiterated RatingBuy$51.67N/A
i
9/30/2017BarclaysReiterated RatingEqual Weight$40.00Low
i
9/1/2017Royal Bank of CanadaReiterated RatingBuy$43.33N/A
i
9/1/2017BMO Capital MarketsReiterated RatingBuy$44.00N/A
i
8/28/2017William BlairReiterated RatingOutperform ➝ OutperformLow
i
Rating by M. Kaczor at William Blair
7/30/2017Canaccord GenuityReiterated RatingBuy$50.00 ➝ $51.67Low
i
Rating by Jason Mills at Canaccord Genuity
7/28/2017Royal Bank of CanadaReiterated RatingBuy$43.33Low
i
7/27/2017CowenReiterated RatingOutperform$43.33 ➝ $45.00Low
i
7/27/2017BarclaysBoost Price TargetEqual Weight$36.00 ➝ $40.00Low
i
7/27/2017Stifel NicolausReiterated RatingBuy ➝ Buy$39.33 ➝ $43.33High
i
7/27/2017Bank of AmericaBoost Price TargetPositive ➝ Buy$46.67 ➝ $50.00High
i
7/27/2017Jefferies Financial GroupBoost Price TargetBuy$38.33 ➝ $44.00High
i
Rating by Steven Desanctis at Jefferies Financial Group Inc.
7/17/2017SunTrust BanksBoost Price TargetBuy$4.67Low
i
6/30/2017Jefferies Financial GroupReiterated RatingBuy$38.33Low
i
Rating by Steven Desanctis at Jefferies Financial Group Inc.
6/28/2017Canaccord GenuityReiterated RatingBuy$50.00Low
i
Rating by Jason Mills at Canaccord Genuity
5/30/2017Royal Bank of CanadaReiterated RatingBuyLow
i
5/30/2017Bank of AmericaBoost Price TargetBuy$40.00 ➝ $46.67Low
i
5/27/2017Jefferies Financial GroupSet Price TargetBuy$38.33N/A
i
Rating by Steven Desanctis at Jefferies Financial Group Inc.
5/16/2017The Goldman Sachs GroupInitiated CoverageConviction-Buy$46.00Low
i
4/26/2017Jefferies Financial GroupReiterated RatingBuyLow
i
4/26/2017Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$38.67 ➝ $40.00High
i
4/26/2017Stifel NicolausBoost Price TargetBuy ➝ Buy$38.00 ➝ $39.33High
i
3/28/2017CowenReiterated RatingOutperform$40.00Medium
i
Rating by Josh Jennings at Cowen Inc
3/27/2017Evercore ISIUpgradeIn-Line ➝ Outperform$32.83 ➝ $36.67Low
i
3/20/2017Northland SecuritiesSet Price TargetBuy$35.00Low
i
Rating by Suraj Kalia at Northland Securities
3/11/2017Northland SecuritiesReiterated RatingOutperform$35.00N/A
i
Rating by Suraj Kalia at Northland Securities
2/27/2017Northland SecuritiesReiterated RatingOutperform$35.00N/A
i
Rating by Suraj Kalia at Northland Securities
2/21/2017Northland SecuritiesReiterated RatingPositive$35.00N/A
i
Rating by Suraj Kalia at Northland Securities
2/8/2017Credit Suisse GroupSet Price TargetBuy$40.00N/A
i
Rating by Matthew Keeler at Credit Suisse Group AG
2/5/2017Deutsche Bank AktiengesellschaftReiterated RatingHold$33.33N/A
i
2/2/2017Canaccord GenuitySet Price TargetBuy$46.67N/A
i
Rating by Jason Mills at Canaccord Genuity
2/2/2017Northland SecuritiesReiterated RatingPositive$35.00N/A
i
2/2/2017SVB LeerinkDowngradeOutperform ➝ Market PerformN/A
i
Rating by D. Antalffy at SVB Leerink LLC
2/2/2017BTIG ResearchDowngradeBuy ➝ NeutralN/A
i
1/3/2017GuggenheimUpgradeNeutral ➝ Buy$40.00N/A
i
12/10/2016JMP SecuritiesReiterated RatingEqual Weight$43.33N/A
i
Rating by John Gillings at JMP Securities
12/10/2016BarclaysReiterated RatingEqual Weight$33.33N/A
i
12/10/2016BTIG ResearchReiterated RatingBuy$36.67N/A
i
12/9/2016Jefferies Financial GroupReiterated RatingBuy$38.33N/A
i
12/9/2016Canaccord GenuityReiterated RatingBuy$46.67N/A
i
Rating by Jason Mills at Canaccord Genuity
12/7/2016CowenReiterated RatingOutperform ➝ Buy$43.33 ➝ $40.00N/A
i
12/1/2016JPMorgan Chase & Co.Set Price TargetBuy$40.00N/A
i
Rating by Michael Weinstein at JPMorgan Chase & Co.
11/29/2016Northland SecuritiesReiterated RatingOutperform$35.00N/A
i
11/28/2016Canaccord GenuitySet Price TargetBuy$46.67N/A
i
Rating by Jason Mills at Canaccord Genuity
11/28/2016Evercore ISIReiterated RatingHold$35.00N/A
i
11/22/2016Canaccord GenuitySet Price TargetBuy$46.67N/A
i
Rating by Jason Mills at Canaccord Genuity
11/8/2016Northland SecuritiesUpgradeMarket Perform ➝ Outperform$35.00N/A
i
10/28/2016SVB LeerinkReiterated RatingOutperform$43.33N/A
i
10/28/2016BTIG ResearchReiterated RatingBuy$36.67N/A
i
10/26/2016Royal Bank of CanadaReiterated RatingOutperform$43.33 ➝ $41.00N/A
i
10/26/2016Jefferies Financial GroupReiterated RatingBuy$41.67 ➝ $38.33N/A
i
10/26/2016Stifel NicolausLower Price TargetBuy$40.67 ➝ $38.00N/A
i
10/26/2016Royal Bank of CanadaLower Price TargetOutperform$43.33 ➝ $41.00N/A
i
9/11/2016Wells Fargo & CompanyReiterated RatingBuyN/A
i
Rating by Larry Biegelsen at Wells Fargo & Company
8/22/2016UBS GroupReiterated RatingBuyN/A
i
Rating by Matt Miksic at UBS Group AG
8/19/2016SVB LeerinkReiterated RatingBuyN/A
i
Rating by Danielle Antalffy at SVB Leerink LLC
8/19/2016Morgan StanleyReiterated RatingBuy$46.67N/A
i
Rating by David Lewis at Morgan Stanley
8/19/2016Evercore ISIReiterated RatingHold$38.33N/A
i
8/18/2016Credit Suisse GroupSet Price TargetBuy$38.67N/A
i
Rating by matthew keeler at Credit Suisse Group AG
8/18/2016Canaccord GenuityReiterated RatingBuy$46.67N/A
i
Rating by Jason Mills at Canaccord Genuity
7/28/2016JPMorgan Chase & Co.Reiterated RatingBuy$43.33N/A
i
Rating by Michael Weinstein at JPMorgan Chase & Co.
7/28/2016JMP SecuritiesBoost Price TargetMarket Outperform$41.67 ➝ $43.33N/A
i
7/27/2016CitigroupBoost Price TargetSell$28.67 ➝ $31.33N/A
i
Rating by Amit Hazan at Citigroup Inc.
7/27/2016BarclaysBoost Price TargetEqual Weight$35.00 ➝ $38.33N/A
i
Rating by Matthew Taylor at Barclays PLC
7/27/2016BMO Capital MarketsReiterated RatingBuy$40.00N/A
i
Rating by Joanne Wuensch at BMO Capital Markets
7/27/2016Deutsche Bank AktiengesellschaftBoost Price TargetHold$33.33 ➝ $38.33N/A
i
7/27/2016Jefferies Financial GroupReiterated RatingBuy$41.67N/A
i
Rating by Raj Denhoy at Jefferies Financial Group Inc.
7/27/2016Canaccord GenuityBoost Price TargetBuy$44.00 ➝ $46.67N/A
i
Rating by Jason Mills at Canaccord Genuity
7/27/2016SVB LeerinkBoost Price TargetOutperform$41.67 ➝ $43.33N/A
i
Rating by Danielle Antalffy at SVB Leerink LLC
7/27/2016BTIG ResearchBoost Price TargetBuy$40.67 ➝ $43.33N/A
i
Rating by Sean Lavin at BTIG Research
7/27/2016UBS GroupReiterated RatingBuy$45.00 ➝ $46.33N/A
i
Rating by Matt Miksic at UBS Group AG
7/27/2016Bank of AmericaUpgradeNeutral ➝ Buy$43.33N/A
i
7/27/2016Morgan StanleyBoost Price TargetOverweight$36.67 ➝ $46.67N/A
i
Rating by David Lewis at Morgan Stanley
7/12/2016JPMorgan Chase & Co.Reiterated RatingBuyN/A
i
Rating by Michael Weinstein at JPMorgan Chase & Co.
6/21/2016William BlairReiterated RatingOutperformN/A
i
6/21/2016Piper Jaffray CompaniesReiterated RatingOverweight$41.00N/A
i
Rating by Brooks West at Piper Jaffray Companies
6/8/2016Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Matthew Keeler at Credit Suisse Group AG
6/8/2016GuggenheimInitiated CoverageNeutralN/A
i
6/1/2016JMP SecuritiesReiterated RatingMkt PerformN/A
i
6/1/2016Canaccord GenuityReiterated RatingBuy$44.00N/A
i
Rating by Jason Mills at Canaccord Genuity
5/25/2016Piper Jaffray CompaniesReiterated RatingOverweight$41.00N/A
i
Rating by Brooks West at Piper Jaffray Companies
5/23/2016Canaccord GenuityBoost Price TargetBuy$41.00 ➝ $44.00N/A
i
Rating by Jason Mills at Canaccord Genuity
4/28/2016Piper Jaffray CompaniesReiterated RatingOverweight$32.33 ➝ $41.00N/A
i
Rating by Brooks West at Piper Jaffray Companies
4/27/2016Jefferies Financial GroupReiterated RatingBuy$35.00 ➝ $41.67N/A
i
Rating by Raj Denhoy at Jefferies Financial Group Inc.
4/27/2016BMO Capital MarketsReiterated RatingBuyN/A
i
Rating by Joanne Wuensch at BMO Capital Markets
4/27/2016Morgan StanleyReiterated RatingBuyN/A
i
Rating by David Lewis at Morgan Stanley
4/27/2016SVB LeerinkReiterated RatingBuy$38.33 ➝ $41.67N/A
i
Rating by Danielle Antalffy at SVB Leerink LLC
4/27/2016Canaccord GenuityBoost Price TargetBuy$37.67 ➝ $41.00N/A
i
Rating by Jason Mills at Canaccord Genuity
4/27/2016Royal Bank of CanadaReiterated RatingOutperform$36.67 ➝ $41.67N/A
i
Rating by Glenn Novarro at Royal Bank of Canada
4/27/2016CowenReiterated RatingOutperform$35.00 ➝ $40.00N/A
i
4/27/2016CitigroupReiterated RatingSell$22.33 ➝ $28.67N/A
i
Rating by Amit Hazan at Citigroup Inc.
4/11/2016JPMorgan Chase & Co.Reiterated RatingOverweight$36.67 ➝ $40.00N/A
i
Rating by Michael Weinstein at JPMorgan Chase & Co.
4/8/2016The Goldman Sachs GroupBoost Price Target$33.33 ➝ $41.67N/A
i
4/7/2016BarclaysLower Price TargetEqual Weight$35.00 ➝ $29.00N/A
i
Rating by Matthew Taylor at Barclays PLC
4/6/2016Morgan StanleyReiterated RatingBuyN/A
i
4/6/2016Bank of AmericaReiterated RatingHold$34.00N/A
i
4/5/2016Northland SecuritiesDowngradeOutperform ➝ Market Perform$35.00N/A
i
4/4/2016Wells Fargo & CompanyReiterated RatingBuyN/A
i
Rating by Larry Biegelsen at Wells Fargo & Company
4/4/2016BarclaysReiterated RatingHold$29.00N/A
i
Rating by Matthew Taylor at Barclays PLC
4/4/2016Canaccord GenuityBoost Price TargetBuy$31.67 ➝ $37.67N/A
i
Rating by Jason Mills at Canaccord Genuity
4/4/2016BMO Capital MarketsLower Price TargetOutperform$38.00 ➝ $31.00N/A
i
Rating by Joanne Wuensch at BMO Capital Markets
4/4/2016SVB LeerinkLower Price TargetOutperform$38.33 ➝ $31.00N/A
i
4/4/2016Jefferies Financial GroupBoost Price TargetBuy$33.33 ➝ $35.00N/A
i
Rating by Raj Denhoy at Jefferies Financial Group Inc.
4/4/2016BTIG ResearchUpgradeNeutral ➝ Buy$38.33N/A
i
Rating by Sean Lavin at BTIG Research
4/4/2016JPMorgan Chase & Co.Reiterated RatingOverweight$32.67 ➝ $36.67N/A
i
Rating by Michael Weinstein at JPMorgan Chase & Co.
4/4/2016Credit Suisse GroupBoost Price TargetOutperform$29.33 ➝ $32.67N/A
i
Rating by Matthew Keeler at Credit Suisse Group AG
4/4/2016Stifel NicolausLower Price TargetBuy$39.00 ➝ $32.67N/A
i
4/4/2016Royal Bank of CanadaBoost Price TargetOutperform$33.33 ➝ $36.67N/A
i
Rating by Glenn Novarro at Royal Bank of Canada
4/2/2016BTIG ResearchUpgradeNeutral ➝ Buy$38.33N/A
i
Rating by Sean Lavin at BTIG Research
4/2/2016UBS GroupReiterated RatingBuy$36.33N/A
i
3/24/2016Jefferies Financial GroupReiterated RatingBuy$33.33N/A
i
3/22/2016UBS GroupReiterated RatingBuy$36.33N/A
i
3/17/2016Nomura SecuritiesInitiated CoverageBuy$33.67N/A
i
3/8/2016SunTrust BanksReiterated RatingBuyN/A
i
Rating by Bruce Nudell at SunTrust Banks, Inc.
3/7/2016SunTrust BanksLower Price TargetNeutral$33.33 ➝ $29.33N/A
i
2/26/2016CitigroupReiterated RatingSell$22.33N/A
i
Rating by Amit Hazan at Citigroup Inc.
2/18/2016Canaccord GenuityBoost Price TargetBuy$30.67 ➝ $31.67N/A
i
Rating by Jason Mills at Canaccord Genuity
2/3/2016Piper Jaffray CompaniesReiterated RatingBuy$30.00 ➝ $32.33N/A
i
Rating by Brooks West at Piper Jaffray Companies
2/3/2016Wells Fargo & CompanyReiterated RatingBuyN/A
i
Rating by Larry Biegelsen at Wells Fargo & Company
2/3/2016Credit Suisse GroupReiterated RatingBuy$29.33N/A
i
Rating by Matthew Keeler at Credit Suisse Group AG
2/3/2016The Goldman Sachs GroupBoost Price TargetBuy$30.33 ➝ $32.00N/A
i
2/3/2016BMO Capital MarketsReiterated RatingBuy$31.00N/A
i
2/3/2016BarclaysReiterated RatingEqual Weight$28.33 ➝ $29.00N/A
i
Rating by Matthew Taylor at Barclays PLC
2/3/2016Canaccord GenuityReiterated RatingBuy$30.00 ➝ $30.67N/A
i
Rating by Jason Mills at Canaccord Genuity
1/21/2016SVB LeerinkReiterated RatingOutperform$31.00N/A
i
1/21/2016SunTrust BanksUpgradeNeutral ➝ Buy$28.67 ➝ $29.33N/A
i
1/7/2016SunTrust BanksInitiated CoverageNeutral$28.67N/A
i
1/6/2016JMP SecuritiesInitiated CoverageMarket PerformN/A
i
1/5/2016Evercore ISIInitiated CoverageHold$28.17N/A
i
1/4/2016JPMorgan Chase & Co.Reiterated RatingBuyN/A
i
Rating by Michael Weinstein at JPMorgan Chase & Co.
1/4/2016Sterne Agee CRTBoost Price TargetBuy$30.00 ➝ $30.67N/A
i
12/29/2015Credit Suisse GroupReiterated RatingBuyN/A
i
Rating by Bruce Nudell at Credit Suisse Group AG
12/29/2015JPMorgan Chase & Co.Boost Price TargetOverweight$28.00 ➝ $32.67N/A
i
12/23/2015Credit Suisse GroupReiterated RatingOutperform$27.00 ➝ $29.33N/A
i
12/17/2015Jefferies Financial GroupBoost Price TargetBuy$30.00 ➝ $33.33N/A
i
12/15/2015BTIG ResearchReiterated RatingHoldN/A
i
Rating by Sean Lavin at BTIG Research
12/10/2015Canaccord GenuityReiterated RatingBuyN/A
i
Rating by Jason Mills at Canaccord Genuity
12/10/2015Stifel NicolausBoost Price TargetBuy$29.83 ➝ $32.50N/A
i
12/10/2015CowenLower Price TargetOutperform$30.83 ➝ $15.50N/A
i
12/9/2015BTIG ResearchReiterated RatingNeutralN/A
i
Rating by Sean Lavin at BTIG Research
(Data available from 11/28/2015 forward)
Edwards Lifesciences logo
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral valve diseases, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $85.26
$83.83
$85.36

50 Day Range

MA: $81.06
$71.69
$85.61

52 Week Range

Now: $85.26
$51.51
$88.00

Volume

918,751 shs

Average Volume

3,558,779 shs

Market Capitalization

$53.14 billion

P/E Ratio

68.21

Dividend Yield

N/A

Beta

0.92